Stay updated on MEDI 4736 Combo in Head/Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI 4736 Combo in Head/Neck Cancer Clinical Trial page.

Latest updates to the MEDI 4736 Combo in Head/Neck Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new drug information related to Squamous Cell Carcinoma of the Head and Neck, specifically mentioning Cetuximab, 5-fluorouracil, Cisplatin, and Carboplatin, while significant details about a previous clinical study have been removed.SummaryDifference11%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
Stay in the know with updates to MEDI 4736 Combo in Head/Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI 4736 Combo in Head/Neck Cancer Clinical Trial page.